Bharat Biotech

The iNCOVACC vaccine is being offered to people over the age of 18 as a booster dose.

The Government of India on Friday approved Bharat Biotech’s nasal vaccine against Covid-19 as a booster for adults.

Drugs Controller General of India (DCGI) gave restricted emergency use authorisation to BharatBiotech's Covaxin for children between the age of 6-12 years, sources said.

A day before Covid vaccine booster shots become available to all Indian adults, the prices of Covaxin and Covishield vaccine have been slashed by more than half on Saturday.

Telangana court has directed news portal The Wire to take down 14 articles it had published on its website on biotechnology company Bharat Biotech, which manufactures Covid-19 vaccine Covaxin.

The World Health Organisation (WHO) on Wednesday approved Bharat Biotech’s Covaxin for emergency use listing for 18 years and above.

In a big relief for parents, the Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group.

Hyderabad-based Bharat Biotech has been granted permission to conduct the phase 2 and phase 3 clinical trials of its COVID-19 vaccine ‘Covaxin’ on children between the 2 to age 18.

After Covishield Covid Vaccine, which arrived in Odisha yesterday, Covaxin vaccine manufactured by Bharat Biotech, also reached Odisha. 20,000 doses of Covaxin Covid 19 vaccine arrived at the Bhubaneswar Airport, Odisha this morning.

Applications for the emergency use of Covid-19 vaccine by Serum Institute of India (SII) and Bharat Biotech are not rejected.